BC is a heterogeneous disease that involves various molecular subtypes such as hormone receptors-positive tumors, human epidermal growth factor (HER-2) over-expressed tumors and the most aggressive subtype, triple-negative tumors [31,32]. This evidence concerns the gene ERBB2 and breast cancer.